Skip to main content

Table 4 Clinical and laboratory findings in complete KD in the 2000–2004 group and the 2010–2014 group (n = 387)

From: Changes in clinical and laboratory features of Kawasaki disease noted over time in Daejeon, Korea

  2000–2004 (n = 210) 2010–2014 (n = 177) P
Age (month) 30.9 ± 21.5 31 ± 18.9 0.938
Sex (M/F) 124/86 109/68 0.677
Fever (day)
 Preadmission 4.8 ± 1.8 4.3 ± 1.6 0.009
 Total 6.9 ± 2.9 6.5 ± 2.3 0.392
Hospitalization (d) 8.5 ± 4.1 6.5 ± 2.8 < 0.001
Repeated IVIG, n (%) 24 (11.4) 22 (12.4) 0.754
CALs, n (%) 45 (21.4) 28 (15.8) 0.192
 Ectasia 42 (20) 27 (15.3) 0.234
 Aneurysm 3 (1.4) 1 (0.6) 0.629
WBC (/mm3) 15,100 ± 5100 15,000 ± 5200 0.880
Neutrophil (%) 64.5 ± 16.2 67.9 ± 14.2 0.031
 Lymphocyte (%) 22.8 ± 12.8 22.1 ± 12.1 0.561
 Hemoglobin (g/dL) 10.8 ± 1.2 11.5 ± 0.8 < 0.001
Platelet (/mm3) 315 ± 147 332 ± 89 0.122
Platelet, follow-up 501 ± 208 443 ± 161 < 0.001
CRP (mg/dL) 10.4 ± 6.8 9.5 ± 5.6 0.192
ESR (mm/h) 56 ± 24 74 ± 32 < 0.001
Total protein (g/dL) 6.5 ± 0.7 6.5 ± 0.6 0.656
Albumin (g/dL) 3.5 ± 0.4 3.8 ± 0.5 < 0.001
AST (IU/L) 89 ± 166 104 ± 156 0.338
ALT (IU/L) 127 ± 161 126 ± 149 0.928
ALT <40 IU, n (%) 89 (42.4) 75 (42.4) 0.918
ALT 40–100 IU, n (%) 45 (21.4) 36 (20.3) 0.900
ALT >100 IU, n (%) 76 (36.2) 66 (37.3) 0.750
  1. Values are mean ± SD or n (%). Abbreviations as in Table 1